Septerna Inc (NASDAQ: SEPN) is a Healthcare company (Biotechnology) with a market capitalization of $1.9B. The Maz Rating grades it against the other companies in its sector.
Septerna Inc's current Maz Rating and its five factor grades are for members: log in to see them.
At $39.68, Septerna Inc trades at 19.6x sales and 4.4x book value. Over the last twelve months it generated about $96M of revenue and a net loss of $61M. It runs a gross margin of 99.6%, an operating margin of -76.2% and a net margin of -61.3%. It shows return on equity of -15.0%, return on invested capital of -14.2% and a free cash flow yield of -4.1%. On the balance sheet: a debt-to-equity ratio of 0.05 and a current ratio of 4.84. Over the past 52 weeks the share price ranged from $21.31 to $53.34, with a beta of 2.20.
Septerna Inc does not currently pay a dividend.
10 Wall Street analyst ratings cover the stock: 1 Strong Buy and 9 Buy, for a Buy consensus. This is the sell side's view, separate from the Maz Rating.
Septerna, Inc., a clinical-stage biotechnology company, discovers and develops G protein-coupled receptor (GPCR) oral small molecule products for the treatment of endocrinology, immunology and inflammation, and metabolic diseases. It develops PTH1R Program, oral small molecule Parathyroid Hormone 1 Receptor agonists for the treatment of hypoparathyroidism; SEP-631, an oral small molecule MRGPRX2 negative allosteric modulator (NAM) for chronic spontaneous urticaria and other mast cell diseases; and TSHR Program, an oral small molecule TSHR NAM for graves’ disease and thyroid eye disease. In addition, it focuses on other therapeutic areas, including neurology, women’s health, cardiovascular disease, and respiratory disease. It has global collaboration and license agreement with Novo Nordisk to discover, develop and commercialize multiple potential oral small molecule therapies for metabolic-related diseases based on certain specified molecular targets. The company was formerly known as GPCR NewCo, Inc. and changed its name to Septerna Inc. in June 2021. Septerna, Inc. was incorporated in 2019 and is headquartered in South San Francisco, California.
Figures are trailing twelve months unless stated. The Maz Rating and Maz Dividend Score rank a company against its own sector; they are not price targets or recommendations.
No. As of September 2026, Septerna Inc (SEPN) is classified as NOT HALAL by Maz Vantage: it fails every published Shariah screening standard it could be measured against (AAOIFI, S&P Global, Dow Jones, MSCI and FTSE).
| Standard | Ratios (value / limit) | Result |
|---|---|---|
| AAOIFI | Debt / Mkt Cap (36m) 0.00% / 30% · (Cash+Inv) / Mkt Cap (36m) 30.9% / 30% · Interest income / Revenue 27.9% / 5% | Fail |
| S&P Global | Debt / Mkt Cap (36m) 0.00% / 33% · (Cash+ST Inv) / Mkt Cap (36m) 26.1% / 33% · Receivables / Mkt Cap (36m) 1.19% / 49% · Interest income / Revenue 27.9% / 5% | Fail |
| Dow Jones | Debt / Mkt Cap (24m) 0.00% / 33.33% · (Cash+ST Inv) / Mkt Cap (24m) 26.1% / 33.33% · Receivables / Mkt Cap (24m) 1.19% / 33.33% · Interest income / Revenue 27.9% / 5% | Fail |
| MSCI | Debt / Avg Assets (4Q) 0.00% / 33.33% · (Cash+ST Inv) / Avg Assets (4Q) 67.6% / 33.33% · Receivables / Avg Assets (4Q) 2.80% / 33.33% · Interest income / Revenue 27.9% / 5% | Fail |
| FTSE | Debt / Total Assets 0.00% / 33.33% · (Cash+ST Inv) / Total Assets 77.3% / 33.33% · (Cash+Recv) / Total Assets 80.8% / 33.33% · Interest income / Revenue 27.9% / 5% | Fail |
No. As of September 2026, Septerna Inc (SEPN) is classified as NOT HALAL by Maz Vantage: it fails every published Shariah screening standard it could be measured against (AAOIFI, S&P Global, Dow Jones, MSCI and FTSE).
No. Septerna Inc is over the AAOIFI limit on (Cash+Inv) / Mkt Cap (36m) and Interest income / Revenue.
About 27.9% of each dividend: Septerna Inc's interest income as a share of its revenue. Give that share to charity; the dividend purification calculator works it out per holding.
The screen is rerun on each quarterly report; the figures here are from the balance sheet dated September 30, 2026 (Q3 2026). A status can change from one quarter to the next as debt, cash and market value move.
See also the list of halal stocks, halal healthcare stocks, the halal stock screener, the dividend purification calculator and the zakat calculator.
A mechanical screen of published financial ratios and the company's line of business, not a religious ruling. It does not test every revenue stream; check with a scholar you trust.